Skip to main content
Top
Published in: International Journal of Legal Medicine 1/2014

01-01-2014 | Review Article

Allergic reactions following contrast material administration: nomenclature, classification, and mechanisms

Authors: Cristian Palmiere, Lionel Comment, Patrice Mangin

Published in: International Journal of Legal Medicine | Issue 1/2014

Login to get access

Abstract

In forensic pathology routine, fatal cases of contrast agent exposure can be occasionally encountered. In such situations, beyond the difficulties inherent in establishing the cause of death due to nonspecific or absent autopsy and histology findings as well as limited laboratory investigations, pathologists may face other problems in formulating exhaustive, complete reports, and conclusions that are scientifically accurate. Indeed, terminology concerning adverse drug reactions and allergy nomenclature is confusing. Some terms, still utilized in forensic and radiological reports, are outdated and should be avoided. Additionally, not all forensic pathologists master contrast material classification and pathogenesis of contrast agent reactions. We present a review of the literature covering allergic reactions to contrast material exposure in order to update used terminology, explain the pathophysiology, and list currently available laboratory investigations for diagnosis in the forensic setting.
Literature
1.
2.
go back to reference Farnam K, Chang C, Teuber S, Gershwin ME (2012) Nonallergic drug hypersensitivity reactions. Int Arch Allergy Immunol 159:327–345PubMedCrossRef Farnam K, Chang C, Teuber S, Gershwin ME (2012) Nonallergic drug hypersensitivity reactions. Int Arch Allergy Immunol 159:327–345PubMedCrossRef
3.
4.
go back to reference Solensky R, Khan DA, Bernstein IL, Bloomberg GR, Castells MC, Mendelson LM, Weiss ME, Bernstein DI, Blessing-Moore J, Cox L, Lang DM, Nicklas RA, Oppenheinmer J, Portnoy JM, Randolph C, Schuller DE, Spector S, Tilles S, Wallace D, Dowling PJ, Dykewicz M, Greenberger PA, Macy EM, May KR, Nguygen MT, Schwartz L, Solensky R, Khan DA, Bernstein IL, Bloomberg GR, Castells MC, Mendelson L, Weiss ME, Bernstein DI, Blessing-Moore J, Cox L, Lang DM, Nicklas R, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles SA, Wallace D, Dowling PJ, Dykewicz MS, Greenberger PA, Macy EM, May KR, Nguyen MT, Schwartz LB (2010) Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 105:259–273CrossRef Solensky R, Khan DA, Bernstein IL, Bloomberg GR, Castells MC, Mendelson LM, Weiss ME, Bernstein DI, Blessing-Moore J, Cox L, Lang DM, Nicklas RA, Oppenheinmer J, Portnoy JM, Randolph C, Schuller DE, Spector S, Tilles S, Wallace D, Dowling PJ, Dykewicz M, Greenberger PA, Macy EM, May KR, Nguygen MT, Schwartz L, Solensky R, Khan DA, Bernstein IL, Bloomberg GR, Castells MC, Mendelson L, Weiss ME, Bernstein DI, Blessing-Moore J, Cox L, Lang DM, Nicklas R, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles SA, Wallace D, Dowling PJ, Dykewicz MS, Greenberger PA, Macy EM, May KR, Nguyen MT, Schwartz LB (2010) Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 105:259–273CrossRef
5.
go back to reference Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259PubMedCrossRef Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259PubMedCrossRef
6.
go back to reference Shah S, Shah H, Khaskheli MN, Akhtar J (2005) Adverse drug reactions: clinical assessment of drug induced disease. J Ayub Med Coll Abbottabad 17:89–91PubMed Shah S, Shah H, Khaskheli MN, Akhtar J (2005) Adverse drug reactions: clinical assessment of drug induced disease. J Ayub Med Coll Abbottabad 17:89–91PubMed
7.
go back to reference Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B (2001) A revised nomenclature for allergy. An EACCI position statement from the EACCI nomenclature task force. Allergy 56:813–824PubMedCrossRef Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B (2001) A revised nomenclature for allergy. An EACCI position statement from the EACCI nomenclature task force. Allergy 56:813–824PubMedCrossRef
8.
go back to reference Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC (2004) Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113:832–836PubMedCrossRef Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC (2004) Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113:832–836PubMedCrossRef
9.
go back to reference Vickery BP, Chin S, Burks AW (2011) Pathophysiology of food allergy. Pediatr Clin N Am 58:363–376CrossRef Vickery BP, Chin S, Burks AW (2011) Pathophysiology of food allergy. Pediatr Clin N Am 58:363–376CrossRef
10.
go back to reference Bonds RS, Midoro-Horiuti T, Goldblum R (2008) A structural basis for food allergy: the role of cross-reactivity. Curr Opin Allergy Clin Immunol 8:82–86PubMedCrossRef Bonds RS, Midoro-Horiuti T, Goldblum R (2008) A structural basis for food allergy: the role of cross-reactivity. Curr Opin Allergy Clin Immunol 8:82–86PubMedCrossRef
11.
go back to reference Romano A, Guéant-Rodriguez RM, Viola M, Gaeta F, Caruso C, Guéant JL (2005) Cross-reactivity among drugs: clinical problems. Toxicology 209:169–179PubMedCrossRef Romano A, Guéant-Rodriguez RM, Viola M, Gaeta F, Caruso C, Guéant JL (2005) Cross-reactivity among drugs: clinical problems. Toxicology 209:169–179PubMedCrossRef
12.
go back to reference Pichler WJ (2004) Immune mechanism of drug hypersensitivity. Immunol Allergy Clin N Am 24:373–397CrossRef Pichler WJ (2004) Immune mechanism of drug hypersensitivity. Immunol Allergy Clin N Am 24:373–397CrossRef
13.
go back to reference Rajan TV (2003) The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends Immunol 24:376–379PubMedCrossRef Rajan TV (2003) The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends Immunol 24:376–379PubMedCrossRef
14.
go back to reference Galli SJ, Tsai M (2010) Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol 40:1843–1851PubMedCentralPubMedCrossRef Galli SJ, Tsai M (2010) Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol 40:1843–1851PubMedCentralPubMedCrossRef
15.
go back to reference Riedl MA, Casillas AM (2003) Adverse drug reactions: types and treatment options. Am Fam Physician 68:1781–1790PubMed Riedl MA, Casillas AM (2003) Adverse drug reactions: types and treatment options. Am Fam Physician 68:1781–1790PubMed
16.
go back to reference Rozieres A, Vocanson M, Saïd BB, Nosbaum A, Nicolas JF (2009) Role of T cells in nonimmediate allergic drug reactions. Curr Opin Allergy Clin Immunol 9:305–310PubMedCrossRef Rozieres A, Vocanson M, Saïd BB, Nosbaum A, Nicolas JF (2009) Role of T cells in nonimmediate allergic drug reactions. Curr Opin Allergy Clin Immunol 9:305–310PubMedCrossRef
17.
go back to reference Singh J, Daftary A (2008) Iodinated contrast media and their adverse reactions. J Nucl Med Technol 36:69–74PubMedCrossRef Singh J, Daftary A (2008) Iodinated contrast media and their adverse reactions. J Nucl Med Technol 36:69–74PubMedCrossRef
18.
go back to reference Trcka J, Schmidt C, Seitz CS, Bröcker EB, Gross GE, Trautmann A (2008) Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? AJR Am J Roentgenol 190:666–670PubMedCrossRef Trcka J, Schmidt C, Seitz CS, Bröcker EB, Gross GE, Trautmann A (2008) Anaphylaxis to iodinated contrast material: nonallergic hypersensitivity or IgE-mediated allergy? AJR Am J Roentgenol 190:666–670PubMedCrossRef
19.
go back to reference Geraldes CF, Laurent S (2009) Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 4:1–23PubMedCrossRef Geraldes CF, Laurent S (2009) Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 4:1–23PubMedCrossRef
21.
go back to reference Böhm I, Heverhagen JT, Klose KJ (2012) Classification of acute and delayed contrast media-induced reactions: proposal of a three step system. Contrast Media Mol Imaging 7:537–541PubMedCrossRef Böhm I, Heverhagen JT, Klose KJ (2012) Classification of acute and delayed contrast media-induced reactions: proposal of a three step system. Contrast Media Mol Imaging 7:537–541PubMedCrossRef
22.
go back to reference Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175:621–628PubMed Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175:621–628PubMed
23.
go back to reference Webb JA, Stacul F, Thomsen HS, Morcos SK (2003) Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 13:181–184PubMedCrossRef Webb JA, Stacul F, Thomsen HS, Morcos SK (2003) Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 13:181–184PubMedCrossRef
24.
go back to reference Hoffmeister HM, Fuhrer G, Platten HP, Heller W (1989) Changes in complement components after intravascular application of contrast media. Adv Exp Med Biol 247B:585–589PubMedCrossRef Hoffmeister HM, Fuhrer G, Platten HP, Heller W (1989) Changes in complement components after intravascular application of contrast media. Adv Exp Med Biol 247B:585–589PubMedCrossRef
25.
go back to reference Hoffmeister HM, Fuhrer G, Platten HP, Heller W (1987) Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media. Rofo 147:673–675PubMedCrossRef Hoffmeister HM, Fuhrer G, Platten HP, Heller W (1987) Complement activation after the intravascular administration of contrast media: a comparison between ionic and nonionic x-ray contrast media. Rofo 147:673–675PubMedCrossRef
26.
go back to reference Mikkonen R, Aronen HJ, Kivisaari L, Piilonen A, Syrjäla M (1997) Plasma levels of prekallikrein, alpha-2-macroglobulin and C1-esterase inhibitor in patients with urticarial reaction to contrast media. Acta Radiol 38:466–473PubMed Mikkonen R, Aronen HJ, Kivisaari L, Piilonen A, Syrjäla M (1997) Plasma levels of prekallikrein, alpha-2-macroglobulin and C1-esterase inhibitor in patients with urticarial reaction to contrast media. Acta Radiol 38:466–473PubMed
27.
go back to reference Hoffmeister HM, Heller W (1996) Radiographic contrast media and the coagulation and complement systems. Invest Radiol 31:591–595PubMedCrossRef Hoffmeister HM, Heller W (1996) Radiographic contrast media and the coagulation and complement systems. Invest Radiol 31:591–595PubMedCrossRef
28.
go back to reference Brockow K (2009) Immediate and delayed reactions to radiocontrast media: is there an allergic mechanism? Immunol Allergy Clin N Am 29:453–468CrossRef Brockow K (2009) Immediate and delayed reactions to radiocontrast media: is there an allergic mechanism? Immunol Allergy Clin N Am 29:453–468CrossRef
29.
go back to reference Brockow K (2012) Immediate and delayed cutaneous reactions to radiocontrast media. Chem Immunol Allergy 97:180–190PubMedCrossRef Brockow K (2012) Immediate and delayed cutaneous reactions to radiocontrast media. Chem Immunol Allergy 97:180–190PubMedCrossRef
30.
go back to reference Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA (1995) Clinical safety of gadopentetate dimeglumine. Radiology 196:439–443PubMed Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA (1995) Clinical safety of gadopentetate dimeglumine. Radiology 196:439–443PubMed
31.
go back to reference Prince MR, Zhang H, Zou Z, Staron RB, Brill PW (2011) Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol 196:138–143CrossRef Prince MR, Zhang H, Zou Z, Staron RB, Brill PW (2011) Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol 196:138–143CrossRef
32.
go back to reference Fineschi V, Monasterolo G, Rosi R, Turillazzi E (1999) Fatal anaphylaxis shock during a fluorescein angiography. Forensic Sci Int 100:137–142PubMedCrossRef Fineschi V, Monasterolo G, Rosi R, Turillazzi E (1999) Fatal anaphylaxis shock during a fluorescein angiography. Forensic Sci Int 100:137–142PubMedCrossRef
33.
go back to reference Su Z, Ye P, Teng Y, Zhang L, Shu X (2012) Adverse reaction in patients with drug allergy history after simultaneous intravenous fundus fluorescein angiography and indocyanine green angiography. J Ocul Pharmacol Ther 28:410–413PubMedCrossRef Su Z, Ye P, Teng Y, Zhang L, Shu X (2012) Adverse reaction in patients with drug allergy history after simultaneous intravenous fundus fluorescein angiography and indocyanine green angiography. J Ocul Pharmacol Ther 28:410–413PubMedCrossRef
34.
go back to reference Garski TR, Staller BJ, Hepner G, Banka VS, Finney RA Jr (1978) Adverse reactions after administration of indocyanine green. JAMA 240:635PubMedCrossRef Garski TR, Staller BJ, Hepner G, Banka VS, Finney RA Jr (1978) Adverse reactions after administration of indocyanine green. JAMA 240:635PubMedCrossRef
35.
go back to reference Iseki K, Onoyama K, Fujimi S, Omae T (1980) Shock caused by indocyanine green dye in chronic hemodialysis patients. Clin Nephrol 14:210PubMed Iseki K, Onoyama K, Fujimi S, Omae T (1980) Shock caused by indocyanine green dye in chronic hemodialysis patients. Clin Nephrol 14:210PubMed
36.
go back to reference Speich R, Saesseli B, Hoffmann U, Neftel KA, Reichen J (1988) Anaphylactoid reactions after indocyanine-green administration. Ann Int Med 109:345–346PubMedCrossRef Speich R, Saesseli B, Hoffmann U, Neftel KA, Reichen J (1988) Anaphylactoid reactions after indocyanine-green administration. Ann Int Med 109:345–346PubMedCrossRef
37.
go back to reference Benya R, Quintana J, Brundage B (1989) Adverse reactions to indocyanine green: a case report and a review of the literature. Catheter Cardiovasc Diagn 17:231–233CrossRef Benya R, Quintana J, Brundage B (1989) Adverse reactions to indocyanine green: a case report and a review of the literature. Catheter Cardiovasc Diagn 17:231–233CrossRef
38.
go back to reference Wolf S, Arend O, Schulte K, Reim M (1992) Severe anaphylactic reaction after indocyanine green fluorescence angiography. Am J Ophthalmol 114:638–639PubMed Wolf S, Arend O, Schulte K, Reim M (1992) Severe anaphylactic reaction after indocyanine green fluorescence angiography. Am J Ophthalmol 114:638–639PubMed
39.
go back to reference Hope-Ross M, Yannuzzi LA, Gragoudas ES, Guyer DR, Slakter JS, Sorenson JA, Krupsky S, Orlock DA, Puliafito CA (1994) Adverse reactions due to indocyanine green. Ophthalmology 101:529–533PubMedCrossRef Hope-Ross M, Yannuzzi LA, Gragoudas ES, Guyer DR, Slakter JS, Sorenson JA, Krupsky S, Orlock DA, Puliafito CA (1994) Adverse reactions due to indocyanine green. Ophthalmology 101:529–533PubMedCrossRef
40.
go back to reference Olsen TW, Lim JI, Capone A Jr, Myles RA, Gilman JP (1996) Anaphylactic shock following indocyanine green angiography. Arch Ophthalmol 114:97PubMedCrossRef Olsen TW, Lim JI, Capone A Jr, Myles RA, Gilman JP (1996) Anaphylactic shock following indocyanine green angiography. Arch Ophthalmol 114:97PubMedCrossRef
41.
go back to reference Bézu C, Coutant C, Salengro A, Daraï E, Rouzier R, Uzan S (2011) Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol 20:e55–e59PubMedCrossRef Bézu C, Coutant C, Salengro A, Daraï E, Rouzier R, Uzan S (2011) Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol 20:e55–e59PubMedCrossRef
42.
go back to reference Barthelmes L, Goyal A, Sudheer P, Mansel RE (2010) Investigation of anaphylactic reaction after patent blue V dye injection. Breast 19:516–520PubMedCrossRef Barthelmes L, Goyal A, Sudheer P, Mansel RE (2010) Investigation of anaphylactic reaction after patent blue V dye injection. Breast 19:516–520PubMedCrossRef
43.
go back to reference Manson AL, Juneja R, Self R, Farquhar-Smith P, Macneill F, Seneviratne SL (2012) Anaphylaxis to Patent Blue V: a case series. Asia Pac Allergy 2:86–89PubMedCentralPubMedCrossRef Manson AL, Juneja R, Self R, Farquhar-Smith P, Macneill F, Seneviratne SL (2012) Anaphylaxis to Patent Blue V: a case series. Asia Pac Allergy 2:86–89PubMedCentralPubMedCrossRef
44.
go back to reference Howard JD, Moo V, Sivalingam P (2011) Anaphylaxis and other adverse reactions to blue dyes: a case series. Anaesth Intensive Care 39:287–292PubMed Howard JD, Moo V, Sivalingam P (2011) Anaphylaxis and other adverse reactions to blue dyes: a case series. Anaesth Intensive Care 39:287–292PubMed
45.
go back to reference Cinar H, Koca B, Kesicioglu T, Karabulut K, Karabicak I, Polat C, Tur AH (2012) Isosulfan blue-induced anaphylactic reaction during sentinel lymph node biopsy in breast cancer. Breast 21:220–222PubMedCrossRef Cinar H, Koca B, Kesicioglu T, Karabulut K, Karabicak I, Polat C, Tur AH (2012) Isosulfan blue-induced anaphylactic reaction during sentinel lymph node biopsy in breast cancer. Breast 21:220–222PubMedCrossRef
46.
go back to reference Ionescu A (2009) Bubble trouble: anaphylactic shock, threatened myocardial infarction, and transient renal failure after intravenous echo contrast for left ventricular cavity opacification preceding dobutamine stress echo. Eur J Echocardiogr 10:707–710PubMedCrossRef Ionescu A (2009) Bubble trouble: anaphylactic shock, threatened myocardial infarction, and transient renal failure after intravenous echo contrast for left ventricular cavity opacification preceding dobutamine stress echo. Eur J Echocardiogr 10:707–710PubMedCrossRef
47.
go back to reference Apostolou E, Deckert K, Puy R, Sandrini A, de Leon MP, Douglass JA, Rolland JM, O’hehir RE (2006) Anaphylaxis to Gelofusine confirmed by in vitro basophil activation test: a case series. Anaesthesia 61:264–268PubMedCrossRef Apostolou E, Deckert K, Puy R, Sandrini A, de Leon MP, Douglass JA, Rolland JM, O’hehir RE (2006) Anaphylaxis to Gelofusine confirmed by in vitro basophil activation test: a case series. Anaesthesia 61:264–268PubMedCrossRef
48.
go back to reference Blokh I, Ganem A, Bonaros EP, Stephen BD, Steinberg B, Rosen SE (2004) Hemodynamic instability after receiving intravenous Perflutren for contrast echocardiography in an elderly female. Echocardiography 21:613–615PubMedCrossRef Blokh I, Ganem A, Bonaros EP, Stephen BD, Steinberg B, Rosen SE (2004) Hemodynamic instability after receiving intravenous Perflutren for contrast echocardiography in an elderly female. Echocardiography 21:613–615PubMedCrossRef
51.
go back to reference Ogawa Y, Grant JA (2007) Mediators of anaphylaxis. Immunol Allergy Clin N Am 27:249–260CrossRef Ogawa Y, Grant JA (2007) Mediators of anaphylaxis. Immunol Allergy Clin N Am 27:249–260CrossRef
52.
go back to reference Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, Bernstein JA, Burks AW, Feldweg AM, Fink JN, Greenberger PA, Golden DB, James JM, Kemp SF, Ledford DK, Lieberman P, Sheffer AL, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Lang D, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles S, Wallace D (2010) The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 126:477–480PubMedCrossRef Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, Bernstein JA, Burks AW, Feldweg AM, Fink JN, Greenberger PA, Golden DB, James JM, Kemp SF, Ledford DK, Lieberman P, Sheffer AL, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Lang D, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles S, Wallace D (2010) The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 126:477–480PubMedCrossRef
53.
go back to reference Edston E, van Hage-Hamsten M (1998) Beta-tryptase measurements post-mortem in anaphylactic deaths and in controls. Forensic Sci Int 93:135–142PubMedCrossRef Edston E, van Hage-Hamsten M (1998) Beta-tryptase measurements post-mortem in anaphylactic deaths and in controls. Forensic Sci Int 93:135–142PubMedCrossRef
54.
go back to reference D’Errico S, Neri M, Riezzo I, Rossi G, Pomara C, Turillazzi E, Fineschi V (2008) Beta-tryptase and quantitative mast-cell increase in a sudden infant death following hexavalent immunization. Forensic Sci Int 179:e25–e29PubMedCrossRef D’Errico S, Neri M, Riezzo I, Rossi G, Pomara C, Turillazzi E, Fineschi V (2008) Beta-tryptase and quantitative mast-cell increase in a sudden infant death following hexavalent immunization. Forensic Sci Int 179:e25–e29PubMedCrossRef
55.
go back to reference Nishio H, Suzuki K (2004) Serum tryptase levels in sudden infant death syndrome in forensic autopsy cases. Forensic Sci Int 139:57–60PubMedCrossRef Nishio H, Suzuki K (2004) Serum tryptase levels in sudden infant death syndrome in forensic autopsy cases. Forensic Sci Int 139:57–60PubMedCrossRef
56.
go back to reference Fineschi V, Cecchi R, Centini F, Reattelli LP, Turillazzi E (2001) Immunohistochemical quantification of pulmonary mast-cells and post-mortem blood dosages of tryptase and eosinophils cationic protein in 48 heroin-related deaths. Forensic Sci Int 120:189–194PubMedCrossRef Fineschi V, Cecchi R, Centini F, Reattelli LP, Turillazzi E (2001) Immunohistochemical quantification of pulmonary mast-cells and post-mortem blood dosages of tryptase and eosinophils cationic protein in 48 heroin-related deaths. Forensic Sci Int 120:189–194PubMedCrossRef
57.
go back to reference Edston E, van Hage-Hamsten M (2003) Mast cell tryptase and hemolysis after trauma. Forensic Sci Int 131:8–13PubMedCrossRef Edston E, van Hage-Hamsten M (2003) Mast cell tryptase and hemolysis after trauma. Forensic Sci Int 131:8–13PubMedCrossRef
58.
go back to reference Edston E, van Hage-Hamsten M (1995) Immunoglobulin E, mast cell-specific tryptase and the complement system in sudden death from coronary artery thrombosis. Int J Cardiol 52:77–81PubMedCrossRef Edston E, van Hage-Hamsten M (1995) Immunoglobulin E, mast cell-specific tryptase and the complement system in sudden death from coronary artery thrombosis. Int J Cardiol 52:77–81PubMedCrossRef
59.
go back to reference Edston E, Eriksson O, van Hage M (2007) Mast cells tryptase in postmortem serum—reference values and confounders. Int J Legal Med 121:275–280PubMedCrossRef Edston E, Eriksson O, van Hage M (2007) Mast cells tryptase in postmortem serum—reference values and confounders. Int J Legal Med 121:275–280PubMedCrossRef
60.
go back to reference Mayer DE, Krauskopf A, Hemmer W, Moritz K, Jarisch R, Reiter C (2011) Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Sci Int 212:96–101PubMedCrossRef Mayer DE, Krauskopf A, Hemmer W, Moritz K, Jarisch R, Reiter C (2011) Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Sci Int 212:96–101PubMedCrossRef
61.
go back to reference Luongo S, Frontalini C, Pesaresi M, Valsecchi M, Tagliabracci A (2011) Histopathological markers for the diagnosis of anaphylactic death. Med Sci Law 51:30–36CrossRef Luongo S, Frontalini C, Pesaresi M, Valsecchi M, Tagliabracci A (2011) Histopathological markers for the diagnosis of anaphylactic death. Med Sci Law 51:30–36CrossRef
62.
go back to reference Schwartz HJ, Yunginger JW, Schwartz LB (1995) Is unrecognized anaphylaxis a cause of sudden unexpected death? Clin Exp Allergy 25:866–870PubMedCrossRef Schwartz HJ, Yunginger JW, Schwartz LB (1995) Is unrecognized anaphylaxis a cause of sudden unexpected death? Clin Exp Allergy 25:866–870PubMedCrossRef
63.
go back to reference Da Broi U, Moreschi C (2011) Post-mortem diagnosis of anaphylaxis: a difficult task in forensic medicine. Forensic Sci Int 204:1–5PubMedCrossRef Da Broi U, Moreschi C (2011) Post-mortem diagnosis of anaphylaxis: a difficult task in forensic medicine. Forensic Sci Int 204:1–5PubMedCrossRef
64.
go back to reference Unkrig S, Hagemeier L, Madea B (2010) Postmortem diagnostics of assumed food anaphylaxis in an unexpected death. Forensic Sci Int 198:e1–e4PubMedCrossRef Unkrig S, Hagemeier L, Madea B (2010) Postmortem diagnostics of assumed food anaphylaxis in an unexpected death. Forensic Sci Int 198:e1–e4PubMedCrossRef
65.
go back to reference Osawa M, Satoh F, Horiuchi H, Tian W, Kugota N, Hasegawa I (2008) Postmortem diagnosis of fatal anaphylaxis during intravenous administration of therapeutic and diagnostic agents: evaluation of clinical laboratory parameters and immunohistochemistry in three cases. Leg Med (Tokyo) 10:143–147CrossRef Osawa M, Satoh F, Horiuchi H, Tian W, Kugota N, Hasegawa I (2008) Postmortem diagnosis of fatal anaphylaxis during intravenous administration of therapeutic and diagnostic agents: evaluation of clinical laboratory parameters and immunohistochemistry in three cases. Leg Med (Tokyo) 10:143–147CrossRef
66.
go back to reference Nishio H, Takai S, Miyazaki M, Horiuchi H, Osawa M, Uemura K, Yoshida K, Mukaida M, Ueno Y, Suzuki K (2005) Usefulness of serum mast cell-specific chymase levels for postmortem diagnosis of anaphylaxis. Int J Legal Med 119:331–334PubMedCrossRef Nishio H, Takai S, Miyazaki M, Horiuchi H, Osawa M, Uemura K, Yoshida K, Mukaida M, Ueno Y, Suzuki K (2005) Usefulness of serum mast cell-specific chymase levels for postmortem diagnosis of anaphylaxis. Int J Legal Med 119:331–334PubMedCrossRef
Metadata
Title
Allergic reactions following contrast material administration: nomenclature, classification, and mechanisms
Authors
Cristian Palmiere
Lionel Comment
Patrice Mangin
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Legal Medicine / Issue 1/2014
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-013-0912-x

Other articles of this Issue 1/2014

International Journal of Legal Medicine 1/2014 Go to the issue